Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.25 Consensus PT from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six analysts that are presently covering the stock, Marketbeat reports. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $12.25.

A number of analysts have recently issued reports on the stock. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating on the stock in a report on Monday, October 21st. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a "strong-buy" rating in a report on Friday, July 19th. Lake Street Capital lowered their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, September 11th. Roth Mkm lowered their target price on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, September 11th. Finally, Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a "buy" rating on the stock in a report on Thursday, October 17th.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BIOX. Oppenheimer & Co. Inc. bought a new position in Bioceres Crop Solutions during the first quarter worth $139,000. Lazard Asset Management LLC bought a new position in Bioceres Crop Solutions during the first quarter worth $212,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in Bioceres Crop Solutions during the second quarter worth $472,000. Oak Family Advisors LLC boosted its position in Bioceres Crop Solutions by 1.9% during the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company's stock worth $728,000 after purchasing an additional 1,208 shares during the period. Finally, Ping Capital Management Inc. bought a new position in Bioceres Crop Solutions during the second quarter worth $448,000. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Stock Down 1.2 %

Shares of NASDAQ BIOX traded down $0.08 during midday trading on Thursday, reaching $6.72. The company's stock had a trading volume of 103,767 shares, compared to its average volume of 81,445. The company has a current ratio of 1.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions has a fifty-two week low of $6.70 and a fifty-two week high of $14.05. The stock has a market capitalization of $422.00 million, a price-to-earnings ratio of 672.00 and a beta of 0.47. The stock has a 50 day simple moving average of $8.37 and a 200-day simple moving average of $10.19.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. The business had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same quarter last year, the business earned ($0.06) earnings per share. Equities research analysts predict that Bioceres Crop Solutions will post 0.39 earnings per share for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.